QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total V…

Recall date

October 10, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0113-2026

FDA classification

Class II

Brand / firm

QuVa Pharma, Inc.

Sold / distributed

U.S. Nationwide

Why it was recalled

Presence of Particulate Matter

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50